Clinical Trial Update: Niacin Plus Statin to Prevent Vascular Events [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing niacin plus a statin to prevent vascular events was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Cardiovascular Disease
• Coronary Artery Disease
• Myocardial Infarction
• Stroke

Drugs mentioned

• Niacin (nicotinic acid)
• Statin (statin)

Snippet

Sponsor: Axio Research. LLC | Conditions: Cardiovascular Diseases, Heart Diseases | Phase 3 | Status: TERMINATED | Results posted: 2015-06-17